N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide

C26H45NO22 — CID 122595050

IUPACN-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide
SMILESCC(=O)NC1[C@H](O[C@]2(O)C(CO)O[C@@H](O[C@@H]3C(CO)OC(O)C(O)[C@H]3O)C(O)[C@H]2O)OC(CO)[C@@H](O[C@@H]2OC(CO)[C@H](O)[C@H](O)C2O)[C@@H]1O
InChIInChI=1S/C26H45NO22/c1-6(32)27-11-13(34)19(47-24-17(38)14(35)12(33)7(2-28)44-24)9(4-30)45-23(11)49-26(42)10(5-31)46-25(18(39)21(26)40)48-20-8(3-29)43-22(41)16(37)15(20)36/h7-25,28-31,33-42H,2-5H2,1H3,(H,27,32)/t7?,8?,9?,10?,11?,12-,13+,14-,15+,16?,17?,18?,19+,20+,21+,22?,23-,24-,25-,26+/m0/s1
InChIKeyBBANTOABHWEXLS-PGDIPMSQSA-N
MW723.63 g/mol
LogP-10.28
Rot. Bonds11

About N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide

N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide (PubChem CID 122595050) has the molecular formula C26H45NO22 and a molecular weight of 723.63 g/mol. Its IUPAC name is N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide.

Molecular Properties

Compound NameN-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide
PubChem CID122595050
Molecular FormulaC26H45NO22
Molecular Weight723.63 g/mol
Exact Mass723.24
IUPAC NameN-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide
SMILESCC(=O)NC1[C@H](O[C@]2(O)C(CO)O[C@@H](O[C@@H]3C(CO)OC(O)C(O)[C@H]3O)C(O)[C@H]2O)OC(CO)[C@@H](O[C@@H]2OC(CO)[C@H](O)[C@H](O)C2O)[C@@H]1O
InChIInChI=1S/C26H45NO22/c1-6(32)27-11-13(34)19(47-24-17(38)14(35)12(33)7(2-28)44-24)9(4-30)45-23(11)49-26(42)10(5-31)46-25(18(39)21(26)40)48-20-8(3-29)43-22(41)16(37)15(20)36/h7-25,28-31,33-42H,2-5H2,1H3,(H,27,32)/t7?,8?,9?,10?,11?,12-,13+,14-,15+,16?,17?,18?,19+,20+,21+,22?,23-,24-,25-,26+/m0/s1
InChIKeyBBANTOABHWEXLS-PGDIPMSQSA-N
XLogP-10.28
TPSA376.93 Ų
H-Bond Donors15
H-Bond Acceptors22
Rotatable Bonds11
Heavy Atoms49
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500723.63
LogP ≤ 5-10.28
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}

Analyze N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide?
The IUPAC name of N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide (CID 122595050) is N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide.
What is the SMILES notation for N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide?
The canonical SMILES for N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide is CC(=O)NC1[C@H](O[C@]2(O)C(CO)O[C@@H](O[C@@H]3C(CO)OC(O)C(O)[C@H]3O)C(O)[C@H]2O)OC(CO)[C@@H](O[C@@H]2OC(CO)[C@H](O)[C@H](O)C2O)[C@@H]1O.
What is the InChIKey of N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide?
The InChIKey is BBANTOABHWEXLS-PGDIPMSQSA-N. The full InChI is InChI=1S/C26H45NO22/c1-6(32)27-11-13(34)19(47-24-17(38)14(35)12(33)7(2-28)44-24)9(4-30)45-23(11)49-26(42)10(5-31)46-25(18(39)21(26)40)48-20-8(3-29)43-22(41)16(37)15(20)36/h7-25,28-31,33-42H,2-5H2,1H3,(H,27,32)/t7?,8?,9?,10?,11?,12-,13+,14-,15+,16?,17?,18?,19+,20+,21+,22?,23-,24-,25-,26+/m0/s1.
What are the key properties of N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide?
N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide has a molecular weight of 723.63 g/mol, XLogP of -10.28, 11 rotatable bonds, 15 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S,4R,5S)-4-hydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3S,4R,6R)-3,4,5-trihydroxy-2-(hydroxymethyl)-6-[(3S,4R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxyoxan-3-yl]acetamide is sourced from PubChem (CID 122595050), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).